Summary

Eligibility
for people ages 18-65 (full criteria)
Location
at UCLA
Dates
study started
estimated completion
Principal Investigator
by Michelle G Craske (ucla)

Description

Summary

The study will compare the effects that two different approaches of exposure therapy have on reducing fear and anxiety in individuals with social anxiety disorder or panic disorder.

Official Title

Inhibitory Learning vs. Habituation: Models of Exposure Therapy

Details

A substantial number of individuals fail to achieve clinically significant symptom relief from exposure-based therapies or experience a return of fear following exposure therapy completion. The prevailing model of exposure therapy for phobias and anxiety disorders purports that fear reduction throughout exposure therapy (i.e., habituation) is reflective of learning and critical to overall therapeutic outcome. However, the amount by which fear - indexed by both self-report, behavioral, and biological correlates of fear expression - reduces by the end of an exposure trial or series of exposure trials is not a reliable predictor of the fear level expressed at follow-up assessment. Developments in the theory and science of fear extinction, and learning and memory, indicate that 'performance during training' is not commensurate with learning at the process level. Inconsistent findings regarding fear reduction are paralleled by findings based in associative learning laboratory paradigms with animals and human samples, specifically that outward expression of fear on the one hand, and conditional associations indicative of underlying learning on the other hand, may not always change in concordance. Rather, 'inhibitory learning' is recognized as being central to extinction, rather than fear during extinction training. The current proposal will compare the 'emotional processing' or habituation-based model of exposure therapy to the competing inhibitory model of exposure that emphasizes learning theory principles. No study has directly compared these approaches to determine which provides optimal symptom relief and return of fear, or mediators and moderators that may contribute to these outcomes. In an effort to address this gap, the current study plans to recruit participants for a treatment trial consisting of two psychotherapies: (a) habituation-based exposure therapy and (b) inhibitory learning-based exposure therapy. The primary goal of this study is to determine if one theoretical approach to exposure outperform the other in reducing symptoms. This study is conducted with individuals meeting diagnostic criteria for social anxiety disorder or panic disorder. Participants will be randomized to either treatment condition and receive 9 sessions of individual psychotherapy focused on either of these disorders. If individual meets diagnostic criteria for both disorders, treatment will be focused on the primary presenting disorder. Participants will complete four assessments over the course of the study, at pre-treatment, mid-treatment, post-treatment, and three-month follow-up. Pre-treatment, mid-treatment, and post-treatment assessments occur over two days, while three-month follow-up requires only a single day and is conducted remotely. These assessments will include semi-structured interviews, self-report questionnaires, and laboratory paradigms designed to examine fear learning processes.

Keywords

Social Anxiety Disorder Panic Disorder inhibitory learning exposure anxiety habituation social anxiety panic Disease Anxiety Disorders Phobia, Social Inhibitory Learning-Based Exposure Habituation-Based Exposure

Eligibility

You can join if…

Open to people ages 18-65

  • Seeking treatment for social anxiety or panic disorder and demonstration of elevated scores using standardized self-report measures and diagnostic interview
  • Age 18 to 65
  • Either stabilized on psychotropic medications or medication-free
  • English-speaking

You CAN'T join if...

  • Serious medical conditions - such as respiratory (e.g., chronic obstructive pulmonary disease), cardiovascular, pulmonary, neurological, muscular-skeletal diseases
  • Pregnancy
  • History of suicidal ideation or self-harm in the past year
  • History of suicide attempts in the last 10 years
  • History of bipolar disorder, psychosis, intellectual disability or organic brain damage
  • Alcohol or substance use disorder within last 6 months
  • Concurrent therapy focused on anxiety

Location

  • University of California, Los Angeles accepting new patients
    Los Angeles California 90095 United States

Lead Scientist at University of California Health

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT04048824
Study Type
Interventional
Last Updated